Know Cancer

or
forgot password

Survivorship Care Planning in Colorectal and Lung Cancer: A Feasibility Study


N/A
21 Years
N/A
Open (Enrolling)
Both
Stage I Colon Cancer, Stage I Rectal Cancer, Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer, Stage IIA Colon Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIA Rectal Cancer, Stage IIB Colon Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIB Rectal Cancer, Stage IIC Colon Cancer, Stage IIC Rectal Cancer, Stage IIIA Colon Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer

Thank you

Trial Information

Survivorship Care Planning in Colorectal and Lung Cancer: A Feasibility Study


PRIMARY OBJECTIVES:

I. To test the feasibility and acceptability of an Advanced Practice Nurse (APN) driven
Survivorship Care Planning (SCP) intervention for colorectal cancer (CRC) and non-small cell
lung cancer (NSCLC) survivors.

SECONDARY OBJECTIVES:

I. Development of the infrastructure and strategy for a larger comparative intervention
study.

OUTLINE:

Patients undergo Survivorship Care Planning comprising disease surveillance, management of
potential long-term and late effects, psycho-social-spiritual issues, and healthy living
recommendations.


Inclusion Criteria:



- Pathologically confirmed diagnosis of stage I, II, or III CRC or NSCLC

- Able to read and understand English

- Able to read and/or understand the study protocol requirements, and provide written
informed consent

- Diagnosis of CRC or NSCLC

- Within three months of completing primary treatment (surgery, chemotherapy,
radiation, or chemoradiation)

- Without recurrent or new primary cancers

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Percentage of attrition based on number of patients who failed to complete the two-month study

Outcome Description:

Descriptive statistics will be presented on those who agree to participate and the proportion of those approached who agree to participate.

Outcome Time Frame:

2 months

Safety Issue:

No

Principal Investigator

Virginia Sun

Investigator Role:

Principal Investigator

Investigator Affiliation:

City of Hope Medical Center

Authority:

United States: Federal Government

Study ID:

12342

NCT ID:

NCT01741636

Start Date:

January 2013

Completion Date:

Related Keywords:

  • Stage I Colon Cancer
  • Stage I Rectal Cancer
  • Stage IA Non-small Cell Lung Cancer
  • Stage IB Non-small Cell Lung Cancer
  • Stage IIA Colon Cancer
  • Stage IIA Non-small Cell Lung Cancer
  • Stage IIA Rectal Cancer
  • Stage IIB Colon Cancer
  • Stage IIB Non-small Cell Lung Cancer
  • Stage IIB Rectal Cancer
  • Stage IIC Colon Cancer
  • Stage IIC Rectal Cancer
  • Stage IIIA Colon Cancer
  • Stage IIIA Non-Small Cell Lung Cancer
  • Stage IIIA Rectal Cancer
  • Stage IIIB Colon Cancer
  • Stage IIIB Non-Small Cell Lung Cancer
  • Stage IIIB Rectal Cancer
  • Stage IIIC Colon Cancer
  • Stage IIIC Rectal Cancer
  • Colonic Neoplasms
  • Rectal Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location

City of Hope Medical CenterDuarte, California  91010